Innovations in mice models ang growing investments in research is expected to drive the growth of US humanized mice model market
According to TechSci Research report, “UnitedStates Humanized Mice Model Market By Service (Breeding, Cryopreservation, Others), By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Others), By Immune Checkpoints (CD47, CD34, PBMC, Others), By Technology (Crispr/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), By Application (Oncology Studies, Immunology and Inflammation Studies, Others), By End-use (Companies, Organizations, Academic and Research Institutes, Contract Research Organizations), By Region, Forecast & Opportunities, 2025”, the United States humanized mice model market is expected to grow at a substantial CAGR during the forecast period on account of continuous research and development activities in pharmaceutical companies. In addition to this, rising demand for humanized mice models is expected to propel the market growth over the next few years. Besides, increasing investments for research in laboratories and institutes is further expected to fuel the market growth. Moreover, growing demand for mice model in cancer research so that genetic basis of tumor development and cancer progression can be studied, is further driving the market growth. However, there are certain factors that might act as major impediments to the growth of United States mice model market during the forecast period such as growing concern for the wellbeing of animals coupled with increasing awareness pertaining to animal rights.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “ United States Humanized Mice Model market”
https://www.techsciresearch.com/report/united-states-humanized-mice-model-market/4855.html
The United States humanized mice model market is segmented based on service, type, immune checkpoints, technology, application, end use, company, company and region. Based on technology, the market can be fragmented into Crispr/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. Here, the Crispr/Cas9 technology segment is expected to register high growth in the market during the next five years. This high growth of this segment can primarily be attributed to numerous advantages it offers such as ease of design, high efficiency, and relatively low cost. Owing to these advantages, CRISPR is the most widely used technique, which is contributing to the large market share of this segment. Based on type, the market is fragmented into inbred mice, outbred mice, genetically engineered mice, hybrid/congenic mice, conditioned/surgically modified mice, and spontaneous mutant mice. Among these, the genetically engineered mice segment dominated the market in terms of largest market share until 2019 and is projected to maintain its dominance in the market during the forecast period as well. This is mainly due to emergence of CRISPR technology that aids in generating gene knockouts. In addition to this, the ongoing investments in the development of new and innovative knockout models is further expected to increase the application areas of these models, which in turn driving the growth of this segment in the country.
Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Creative Biolabd, Horizon Discovery Group, Ingenious Targeting Laboratory, Biocytogen and others are some of the leading players operating in United States humanized mice model market. The companies operating in the market are coming with new developments in order to boost their market share.
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=4855
Customers can also request for 10% free customization on this report.
“United States humanized mice model market is expected to grow at a high pace during the forecast period owing to surging focus on biomedical research in the country. Additionally, rising demand for monoclonal antibody production is further expected to spur the market growth. Furthermore, presence of large market players is expected to create lucrative opportunities for the market growth over the coming years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Humanized Mice Model Market By Service (Breeding, Cryopreservation, Others), By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Others), By Immune Checkpoints (CD47, CD34, PBMC, Others), By Technology (Crispr/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), By Application (Oncology Studies, Immunology and Inflammation Studies, Others), By End-use (Companies, Organizations, Academic and Research Institutes, Contract Research Organizations), By Region, Forecast & Opportunities, 2025”, has evaluated the future growth potential of United States humanized mice model market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in United States humanized mice model market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]